Shares of genedrive plc (LON:GDR – Get Free Report) shot up 9.9% during trading on Tuesday . The company traded as high as GBX 2.45 ($0.03) and last traded at GBX 2.45 ($0.03). 10,326,631 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 15,053,750 shares. The stock had previously closed at GBX 2.23 ($0.03).
genedrive Trading Down 4.0 %
The company has a market cap of £12.25 million, a P/E ratio of -57.13 and a beta of 0.06. The business’s 50-day moving average price is GBX 2.97 and its 200 day moving average price is GBX 3.41. The company has a debt-to-equity ratio of 8.57, a quick ratio of 5.52 and a current ratio of 1.63.
Insider Activity at genedrive
In other genedrive news, insider Ian David Gilham bought 1,000,000 shares of genedrive stock in a transaction dated Wednesday, August 14th. The stock was bought at an average cost of GBX 3 ($0.04) per share, for a total transaction of £30,000 ($39,447.73). 14.78% of the stock is currently owned by company insiders.
About genedrive
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Featured Articles
- Five stocks we like better than genedrive
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Emerging Markets: What They Are and Why They Matter
- What is the Hang Seng index?
- Recession or Not, These 3 Stocks Are Winners
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.